ARTES joins fight against COVID-19 with VLP vaccine platforms
ARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read moreARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read moreThe FDA has shown green light for MenQuadfi, Sanofi’s innovative meningococcal (MenACWY) vaccine. The U.S. Food and Drug Administration (FDA)
Read moreThe first intermediate analysis of the Phase I Zika vaccine candidate sample (mRNA-1893) reveals that the dosage levels of 10
Read moreWhile COVID-19 transmission is expanding, the Japanese government has agreed to raise its Avigan® Tablet (favipiravir) stockpile, which is estimated
Read moreItalian IT and complex database consultancy Nubilaria is offering it’s cutting edge ACTide EDC web platform free of charge to
Read moreAt the end of March, the American medical devices and healthcare company Abbott Laboratories announced that the U.S. Food and
Read moreInovio Pharmaceuticals stock soared by +16.36% on Friday, as HPV drug VGX-3100 showed promise in Phase 2 Trial. Shares of
Read moreRoche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read moreThe very first biosafety (level 4) BSL-4 laboratory in mainland China was opened in 2015, at a cost of around
Read moreWith more than 100,000 confirmed novel coronavirus cases reported across 93 countries and 3400+ deaths, a coronavirus vaccine is needed
Read more